Levothyroxine Sodium 0.112 mg

1 INDICATIONS AND USAGE Hypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use • Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium tablets may induce hyperthyroidism [see Warnings and Precautions (5.1) ]. • Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. Levothyroxine sodium tablets are a L-thyroxine (T4) indicated in adult and pediatric patients, including neonates, for: • Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. ( 1 ) • Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. ( 1 ) Limitations of Use: • not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients • Not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis

Mylan Pharmaceuticals Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] pain` `[4] nausea` `[5] headache` `[6] dyspnoea` `[7] rash` `[8] diarrhoea` `[9] alopecia` `[10] off label use`

5 years ago

OVAL RED L 9 M

16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied

LEVOTHYROXINE SODIUM Tablets, USP are available containing 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 200 mcg or 300 mcg of

LEVOTHYROXINE SODIUM, USP. They are available as follows: The 25 mcg tablets are orange, capsule-shaped, scored tablets debossed with L to the left of the score and 4 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1800-77 bottles of 90 tablets NDC 0378-1800-10 bottles of 1000 tablets The 50 mcg tablets are white, capsule-shaped, scored tablets debossed with L to the left of the score and 5 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1803-77 bottles of 90 tablets NDC 0378-1803-10 bottles of 1000 tablets The 75 mcg tablets are violet, capsule-shaped, scored tablets debossed with L to the left of the score and 6 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1805-77 bottles of 90 tablets NDC 0378-1805-10 bottles of 1000 tablets The 88 mcg tablets are olive, capsule-shaped, scored tablets debossed with L to the left of the score and 7 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1807-77 bottles of 90 tablets NDC 0378-1807-10 bottles of 1000 tablets The 100 mcg tablets are yellow, capsule-shaped, scored tablets debossed with L to the left of the score and 8 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1809-77 bottles of 90 tablets NDC 0378-1809-10 bottles of 1000 tablets The 112 mcg tablets are rose, capsule-shaped, scored tablets debossed with L to the left of the score and 9 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1811-77 bottles of 90 tablets NDC 0378-1811-10 bottles of 1000 tablets The 125 mcg tablets are gray, capsule-shaped, scored tablets debossed with L to the left of the score and 10 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1813-77 bottles of 90 tablets NDC 0378-1813-10 bottles of 1000 tablets The 137 mcg tablets are turquoise, capsule-shaped, scored tablets debossed with L to the left of the score and 15 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1823-77 bottles of 90 tablets NDC 0378-1823-10 bottles of 1000 tablets The 150 mcg tablets are blue, capsule-shaped, scored tablets debossed with L to the left of the score and 11 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1815-77 bottles of 90 tablets NDC 0378-1815-10 bottles of 1000 tablets The 175 mcg tablets are lilac, capsule-shaped, scored tablets debossed with L to the left of the score and 12 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1817-77 bottles of 90 tablets NDC 0378-1817-10 bottles of 1000 tablets The 200 mcg tablets are pink, capsule-shaped, scored tablets debossed with L to the left of the score and 13 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1819-77 bottles of 90 tablets NDC 0378-1819-10 bottles of 1000 tablets The 300 mcg tablets are green, capsule-shaped, scored tablets debossed with L to the left of the score and 14 to the right of the score on one side of the tablet and M on the other side. NDC 0378-1821-77 bottles of 90 tablets Storage and Handling Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site